Related Experiment Video
Updated: Dec 6, 2025

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
Published on: June 2, 2023
Immunomodulation for the Treatment of Fungal Infections: Opportunities and Challenges
1Department of Microbiology, Immunology and Parasitology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Abstract:
Opportunistic fungal infections are major causes of morbidity and mortality in patients with single or multiple defects in their immunity. Antifungal agents targeting the pathogen remain the treatment of choice for fungal infections. However, antifungal agents are toxic to the host mainly due to the close evolutionary similarity of fungi and humans. Moreover, antifungal therapy is ineffective in patients with immunosuppression. For this reason, there is an increased demand to develop novel strategies to enhance immune function and augment the existing antifungal drugs. In recent times, targeting the immune system to improve impaired host immune responses becomes a reasonable approach to improve the effectiveness of antifungal drugs. In this regard, immunomodulating therapeutic agents that turn up the immune response in the fight against fungal infections hold promise for enhancing the efficacy and safety of conventional antifungal therapy. In general, immunomodulating therapies are safe with decreased risk of resistance and broad spectrum of activity. In this review, therefore, clinical evidences supporting the opportunities and challenges of immunomodulation therapies in the treatment of invasive fungal infections are included.
Insights
Immunomodulation therapies enhance immune responses to fight opportunistic fungal infections, offering a safer and more effective alternative to conventional antifungal drugs, especially for immunocompromised patients.
Area of Science:
- Mycology
- Immunology
- Pharmacology
Background:
- Opportunistic fungal infections cause significant morbidity and mortality, particularly in immunocompromised individuals.
- Conventional antifungal agents pose toxicity risks due to host-pathogen evolutionary similarity and are often ineffective in immunosuppressed patients.
- Novel strategies are needed to enhance host immunity and improve antifungal drug efficacy.
Purpose of the Study:
- To review clinical evidence on immunomodulation therapies for invasive fungal infections.
- To explore the opportunities and challenges associated with using immunomodulation in antifungal treatment.
- To highlight the potential of enhancing host immune responses against fungal pathogens.
Main Methods:
- Review of clinical evidence and scientific literature.
- Analysis of immunomodulatory therapeutic agents targeting host immune responses.
- Evaluation of safety, efficacy, and resistance profiles of immunomodulation.
Main Results:
- Immunomodulating agents show promise in boosting the immune system to combat fungal infections.
- These therapies can enhance the efficacy and safety of conventional antifungal drugs.
- Immunomodulation generally presents a safe profile with a broad spectrum of activity and reduced risk of resistance.
Conclusions:
- Targeting host immune responses through immunomodulation is a viable strategy for treating invasive fungal infections.
- Immunomodulation offers a promising approach to improve outcomes for patients with compromised immunity.
- Further clinical evidence supports the integration of immunomodulation into antifungal treatment paradigms.
Related Concept Videos
Tumor Immunotherapy
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Fungal Phylum Microsporidia
Microorganisms in Medicine and Therapeutics
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

